Stock Taper
STAA
STAAR SURGICAL COMPANY
NASDAQ
$22.11
▼ DOWN 1.25% (-0.28)

KEY STATISTICS

Market Cap$1.10 B
52w High$35.87
52w Low$15.59
Dividend Yield
Frequency
P/E38.79
Volume442.98K
Shares Out.49.79M

COMPANY

LEADERSHIP

Warren Foust
CHIEF EXECUTIVE
Warren Foust

COMPENSATION 2026

Salary$580,000
Stock Awards$6,836,000
Incentive Plan Pay$0
All Other Comp.$106,385
Total$7,522,385

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 24, 1992
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
921

PRICE TARGET

Target High$40.00
Target Low$27.00
Target Median$31.50
Target Consensus$31.50

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$79.10M
NOV
4
WED

SPLIT RECORD

DATETYPERATIO
1992-05-18Reverse1:2
1990-11-01Reverse1:2
1984-11-09Forward2:1
1984-07-03Forward2:1

PRICE

$22.11 ▼ DOWN 1.25% (−$0.28)
OVERLAYS
$21.90$22.05$22.20$22.359:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM22.11

About STAAR Surgical Company

https://www.staar.com ↗

STAAR Surgical designs, manufactures, and markets implantable eye lenses and delivery systems for vision correction and cataract surgery, serving ophthalmologists worldwide.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT STAAR SURGICAL COMPANY IS KNOWN FOR

EVO/EVO+ Visian Implantable Collamer Lenses (ICL)
EVO/EVO+ Visian Implantable Collamer Lenses (ICL)

The EVO Visian ICL is FDA-approved implantable lens correcting myopia and astigmatism, placed behind the iris in a minimally invasive procedure, offering a lens-based alternative to LASIK with an expanded age range.

Revenue by Products

IconPRODUCTQ2-2024Q3-2024Q4-2024Q1-2025
Implantable Collamer Lenses$99.36M $89.1M $146.29M $41.5M
Other Surgical Products$1.15M $1.09M

Revenue by Geography

MapREGIONQ4-2018Q1-2019Q2-2019Q3-2019
CHINA$10.85M $11.77M $19.39M $18.36M
Other Countries$7.65M $12M $13.99M $13.35M
JAPAN$5.37M $5.52M $6.28M $7.34M
KOREA REPUBLIC OF$3.29M

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity3
Return On Assets3
Debt To Equity3
Price To Earnings1
Price To Book2
Overall Score3

INSIDER TRADES

OFFICER: PRESIDENT AND CEO
Foust Warren
Purchase · 3.7K shares
2026-08-14
OFFICER: CHIEF FINANCIAL OFFICER & EVP
ANDREWS DEBORAH J
Purchase · 5.2K shares
2026-08-14
OFFICER: CHIEF FINANCIAL OFFICER & EVP
ANDREWS DEBORAH J
Purchase · 29.2K shares
2026-08-14
OFFICER: CHIEF DEVELOPMENT OFFICER
Michna Magda
Purchase · 1.1K shares
2026-08-14

MOST RECENT ANALYST GRADES

GRADE SUMMARY
NEUTRAL 2
BUY 2
HOLD 1
OUTPERFORM 1
SELL 1
EQUAL WEIGHT 1
8 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
PLSE$47.57COMPARE
PGEN$6.95COMPARE
NVCR$17.82COMPARE
BLFS$36.38COMPARE
AZTA$32.95COMPARE
KMTS$25.64COMPARE
ORIC$13.24COMPARE
BBNX$19.72COMPARE